Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daishenning is a traditional Dai ethnic medicinal preparation developed by the Xishuangbanna Dai Autonomous Prefecture Dai Medical Hospital. Formulated as granules, it is an investigational herbal therapy currently being evaluated in Phase II clinical trials for the treatment of chronic kidney disease (CKD). As a botanical-based medicine, it is designed to improve renal function and manage the progression of CKD, likely through the synergistic effects of multiple active components found in its constituent herbs, although its specific molecular targets and mechanism of action are not yet fully characterized in standard pharmacological literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Daishenning (Xishuangbanna Dai Autonomous Prefecture Dai Medicine Hospital).